Logos Global Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-90,000	Closed	-$2.43M	–	63
2024 Q2	$2.43M	Buy	+90,000	New	+$2.43M	0.2%	47
2020 Q2	–	Sell	-37,062	Closed	-$2.68M	–	58
2020 Q1	$2.68M	Buy	+37,062	New	+$2.68M	1.02%	33